Biohaven [BHVN] vs Vertex [VRTX] Detailed Stock Comparison
Biohaven
NYSE
Loading...
Vertex
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Biohaven wins in 3 metrics, Vertex wins in 12 metrics, with 0 ties. Vertex appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Biohaven | Vertex | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -1.68 | 28.08 | Biohaven |
| Price-to-Book Ratio | 11.54 | 5.90 | Vertex |
| Debt-to-Equity Ratio | 25.63 | 8.89 | Vertex |
| PEG Ratio | 0.04 | -0.22 | Vertex |
| EV/EBITDA | -1.27 | 20.09 | Biohaven |
| Profit Margin (TTM) | 0.00% | 31.86% | Vertex |
| Operating Margin (TTM) | 0.00% | 38.93% | Vertex |
| EBITDA Margin (TTM) | N/A | 38.93% | N/A |
| Return on Equity | -295.94% | 22.77% | Vertex |
| Return on Assets (TTM) | -103.41% | 13.09% | Vertex |
| Free Cash Flow (TTM) | $-586.50M | $-978.00M | Biohaven |
| 1-Year Return | -62.59% | -17.90% | Vertex |
| Price-to-Sales Ratio (TTM) | N/A | 8.87 | N/A |
| Enterprise Value | $1.18B | $96.45B | Vertex |
| EV/Revenue Ratio | N/A | 8.45 | N/A |
| Gross Profit Margin (TTM) | N/A | 86.25% | N/A |
| Revenue per Share (TTM) | $0 | $44 | Vertex |
| Earnings per Share (Diluted) | $-7.46 | $14.07 | Vertex |
| Beta (Stock Volatility) | 3.50 | 0.44 | Vertex |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Biohaven vs Vertex Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Biohaven | 6.34% | -0.64% | 16.23% | 1.17% | -56.07% | -58.13% |
| Vertex | -0.59% | 0.59% | -15.96% | -8.96% | -17.97% | -2.62% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Biohaven | -62.59% | 113.84% | 113.84% | -12.84% | -12.84% | -12.84% |
| Vertex | -17.90% | 40.27% | 46.36% | 194.76% | 1,046.94% | 2,164.30% |
Performance & Financial Health Analysis: Biohaven vs Vertex
| Metric | BHVN | VRTX |
|---|---|---|
| Market Information | ||
| Market Cap | $1.55B | $101.31B |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 2,013,830 | 1,787,010 |
| 90 Day Avg. Volume | 1,957,297 | 2,014,950 |
| Last Close | $15.61 | $395.12 |
| 52 Week Range | $12.79 - $55.70 | $362.50 - $519.88 |
| % from 52W High | -71.97% | -24.00% |
| All-Time High | $67.86 (Jun 03, 2019) | $519.88 (Nov 04, 2024) |
| % from All-Time High | -77.00% | -24.00% |
| Growth Metrics | ||
| Quarterly Revenue Growth | N/A | 0.12% |
| Quarterly Earnings Growth | N/A | 0.12% |
| Financial Health | ||
| Profit Margin (TTM) | 0.00% | 0.32% |
| Operating Margin (TTM) | 0.00% | 0.39% |
| Return on Equity (TTM) | -2.96% | 0.23% |
| Debt to Equity (MRQ) | 25.63 | 8.89 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $1.27 | $67.02 |
| Cash per Share (MRQ) | $3.83 | $24.90 |
| Operating Cash Flow (TTM) | $-645,078,016 | $3.85B |
| Levered Free Cash Flow (TTM) | $-508,353,632 | $2.91B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Biohaven vs Vertex
| Metric | BHVN | VRTX |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -1.68 | 28.08 |
| Forward P/E | -2.32 | 21.05 |
| PEG Ratio | 0.04 | -0.22 |
| Price to Sales (TTM) | N/A | 8.87 |
| Price to Book (MRQ) | 11.54 | 5.90 |
| Market Capitalization | ||
| Market Capitalization | $1.55B | $101.31B |
| Enterprise Value | $1.18B | $96.45B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | N/A | 8.45 |
| Enterprise to EBITDA | -1.27 | 20.09 |
| Risk & Other Metrics | ||
| Beta | 3.50 | 0.44 |
| Book Value per Share (MRQ) | $1.27 | $67.02 |
Financial Statements Comparison: Biohaven vs Vertex
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | BHVN | VRTX |
|---|---|---|
| Revenue/Sales | $0 | $2.96B |
| Cost of Goods Sold | N/A | $407.50M |
| Gross Profit | N/A | $2.56B |
| Research & Development | $187.58M | $978.40M |
| Operating Income (EBIT) | $-221.56M | $1.15B |
| EBITDA | $-219.32M | $1.34B |
| Pre-Tax Income | $-221.07M | $1.28B |
| Income Tax | $609,000 | $250.10M |
| Net Income (Profit) | $-221.68M | $1.03B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | BHVN | VRTX |
|---|---|---|
| Cash & Equivalents | $98.42M | $4.67B |
| Total Current Assets | $382.76M | $10.01B |
| Total Current Liabilities | $164.03M | $3.78B |
| Long-Term Debt | $30.80M | $1.65B |
| Total Shareholders Equity | $259.50M | $16.50B |
| Retained Earnings | $-1.57B | $10.25B |
| Property, Plant & Equipment | $36.78M | $2.63B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | BHVN | VRTX |
|---|---|---|
| Operating Cash Flow | $-164.28M | $404.90M |
| Capital Expenditures | $-461,000 | $-40.70M |
| Free Cash Flow | $-165.59M | $778.20M |
| Debt Repayment | N/A | $-1.30M |
| Common Stock Repurchase | N/A | $-696.60M |
Short Interest & Institutional Ownership Analysis
| Metric | BHVN | VRTX |
|---|---|---|
| Shares Short | 12.71M | 4.36M |
| Short Ratio | 6.72 | 4.04 |
| Short % of Float | 0.14% | 0.02% |
| Average Daily Volume (10 Day) | 2,013,830 | 1,787,010 |
| Average Daily Volume (90 Day) | 1,957,297 | 2,014,950 |
| Shares Outstanding | 101.22M | 256.94M |
| Float Shares | 88.38M | 255.58M |
| % Held by Insiders | 0.12% | 0.00% |
| % Held by Institutions | 0.83% | 0.98% |
Dividend Analysis & Yield Comparison: Biohaven vs Vertex
| Metric | BHVN | VRTX |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |